Connect your AI

Tandem Diabetes Care TNDM Total Equity

Total Equity at other companies

InsuletPODD

$1.3B-2.1%

MedtronicMDT

$49.46B+3.0%

AdaptHealthAHCO

$1.51B-3.9%

MannkindMNKD

-$59.2M-1.0%

AbbottABT

$52.06B+6.7%

OmnicellOMCL

$1.26B0.0%

Other financials

Income statement

Revenue$247.2M+5.5%

Gross profit$136.8M+15.5%

Operating income-$17.4M+85.6%

Net income-$20.4M+84.4%

EPS (diluted)-$0.30+84.8%

Balance sheet

Cash & equivalents$179.3M+235%

Total debt$734.7M+49.0%

Total assets$1.2B+25.1%

Cash flow

Operating cash flow$11.1M+160%

CapEx$6.3M+111%

Free cash flow$4.8M+123%

Valuation

Market cap$1.03B-23.6%

Enterprise value$1.58B-11.3%

P/S1×-0.4×

Profitability

Gross margin54.9%+2.7pp

Operating margin-8.2%-2.9pp

Net margin-9.2%-3.1pp

FCF margin-0.8%-0.4pp

Returns & leverage

Return on equity-65.7%-14.7pp

Debt / equity5.5×+2.4×

Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tandem Diabetes Care's total equity?: Tandem Diabetes Care (TNDM) reported total equity of $132.4M in Q1 2026.
How has Tandem Diabetes Care's total equity changed year-over-year?: Tandem Diabetes Care's total equity decreased by 14.7% year-over-year, from $155.29M to $132.4M.
What is the long-term trend for Tandem Diabetes Care's total equity?: Over 5 years (2020 to 2025), Tandem Diabetes Care's total equity has grown at a -15.8% compound annual growth rate (CAGR), from $366.31M to $155.17M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.